Library / regulatory-reference
Romania: National Agency for Medicines and Medical Devices (ANMDMR)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The National Agency for Medicines and Medical Devices of Romania, known by its Romanian initials ANMDMR, is the country's national regulatory authority for medicines and medical devices.
Romania is one of Europe's larger markets, and the agency's registration and pricing-linked decisions operate in a system known for tight reimbursement controls and periodic supply pressures.
How products enter the market
Medicines require marketing authorization through national or European procedures after evaluation of quality, safety and efficacy, and establishments are licensed and inspected by the agency.
Post-market work includes safety monitoring within the European alert network, and Romania's pricing and reimbursement rules strongly shape which authorized products actually reach the market.
Regional and international role
The agency is an active member of the European regulatory network, contributing to shared scientific work.
Its experience managing parallel-export tension between low national prices and supply availability is studied across Europe.
Using this profile
The agency publishes regulations, registers and alerts in Romanian, with English material, through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: Romania illustrates the price-pressured big market: authorization inside Europe's network, with domestic pricing rules driving availability debates.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.